Alaunos Therapeutics, Inc. Leasehold Improvements, Gross
Alaunos Therapeutics, Inc. (TCRT) had Leasehold Improvements, Gross of $990.00 thousand as of 2015-12-31, per its 10-K filed 2016-02-24.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:LeaseholdImprovementsGross · last filed 2016-02-24
- 2015-12-31: Leasehold Improvements, Gross $990.00K.
- 2014-12-31: Leasehold Improvements, Gross $927.00K.
- 2013-12-31: Leasehold Improvements, Gross $841.00K.
- 2012-12-31: Leasehold Improvements, Gross $1.36M.
| Period end | Leasehold Improvements, Gross |
|---|---|
| 2015-12-31 | $990.00K 10-K · filed 2016-02-24 |
| 2014-12-31 | $927.00K 10-K · filed 2016-02-24 |
| 2013-12-31 | $841.00K 10-K · filed 2015-02-26 |
| 2012-12-31 | $1.36M 10-K · filed 2014-03-03 |
| 2011-12-31 | $890.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |